Skip to main content
Topics
Video
Provider
Payer
Pharma
ANZ
ASIA
EMEA
Global Edition
Click Therapeutics
Click Therapeutics granted FDA market authorization for digital migraine drug
By
Anthony Vecchione
|
04:34 pm |
April 15, 2025
Data from the clinical trial might give patients a new option for treating migraines.